Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FNN7N
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,915
Award facts
- Contract value 100% obligated
- $14,915.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $14,915.06 firm fixed price delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml syringes. This non-set-aside delivery order, issued on December 1, 2025, with an ultimate completion date of December 2, 2025, will be performed at the company's corporate office in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication used to treat moderate-to-severe atopic dermatitis, eosinophilic esophagitis, and asthma, making this acquisition part of the Department of Defense's pharmaceutical supply chain supporting military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement valued through December 2026. This comprehensive global pharmaceutical support vehicle enables the contractor to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and medical devices across multiple therapeutic domains. AmerisourceBergen Drug Corp's position as a major pharmaceutical distributor and federal medical procurement vendor reflects the company's capability to meet competitive federal healthcare supply requirements across the military healthcare system.
Quick answers
Who was awarded contract SPE2DR26FNN7N?
SPE2DR26FNN7N was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 1, 2025.
How much is contract SPE2DR26FNN7N worth?
The government has obligated $14,915 on SPE2DR26FNN7N.
Is contract SPE2DR26FNN7N an order under another contract?
Yes. SPE2DR26FNN7N is a delivery order under SPE2DR25D1021, an indefinite delivery contract.
Was contract SPE2DR26FNN7N competed?
The extent of competition for SPE2DR26FNN7N was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award